Federal Register of Legislation - Australian Government

Primary content

PB 66 of 2013 Arrangements as made
This instrument amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (No. PB 118 of 2010) to change ‘the Responsible Person’ in the Special Arrangement for the listed drug Macrogol.
Administered by: Health
Made 23 Sep 2013
Registered 24 Sep 2013
Tabled HR 12 Nov 2013
Tabled Senate 12 Nov 2013
Date of repeal 02 Oct 2013
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

I, STEVE DUNLOP, Acting Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Medical Research, make this Instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated         23 September 2013

 

 

 

 

 

 

 

 

 

 

 

STEVE DUNLOP

Acting Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

 

 

 

1       Name of Instrument

(1)          This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2013 (No 2).

(2)          This Instrument may also be cited as PB 66 of 2013.

2       Commencement

This Instrument commences on 1 October 2013.

3       Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010

Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010).

 

.


Schedule 1     Amendments

                                       

 

[1]           Schedule 1, entry for Macrogol 3350 in the form Sachets containing powder for oral solution 13.125 g with electrolytes, 30

omit from the column headed ‘Responsible Person; for the brand ‘LaxaCon’: GM substitute: GN

 

 

[2]           Schedule 2, after BY

omit:

 

GM

Ascent Pharma Pty Ltd

68 118 734 795

insert:

 

GN

Actavis Pty Ltd

17 003 854 626